Radiotherapy in Gynecological Oncology
Özet
Gynecologic malignancies including cervical, endometrial, ovarian, and vulvar cancers represent a major cause of cancer morbidity and mortality in women worldwide. Despite progress in surgery and systemic therapy, radiotherapy (RT) remains a cornerstone in their multidisciplinary management. This review summarizes current evidence (2020–2025) on the role of radiotherapy in gynecologic oncology, highlighting modern techniques, guideline updates, and evolving clinical indications across major tumor types. Recent international guidelines (ESGO, ESTRO, ASTRO, NCCN) and peer-reviewed studies were reviewed to assess the role of external beam radiotherapy, brachytherapy, and stereotactic body radiotherapy (SBRT) in gynecologic cancers, with emphasis on survival outcomes, toxicity, and technical advances. In cervical cancer, concurrent chemoradiation followed by image-guided brachytherapy remains standard for locally advanced disease, with underutilization of brachytherapy linked to inferior survival. In vulvar carcinoma, adjuvant RT or chemoradiotherapy is indicated for positive or close margins and nodal metastases, while IMRT/IGRT improves tissue sparing and toxicity profiles. In ovarian cancer, renewed interest has emerged in consolidative and oligometastatic settings; IMRT and SBRT demonstrate favorable local control and acceptable toxicity, particularly in chemoresistant or clear cell histologies. In endometrial cancer, adjuvant RT especially vaginal brachytherapy reduces locoregional recurrence in intermediate- and high-risk groups, while molecular profiling increasingly guides adjuvant decisions. In uterine sarcomas, adjuvant RT may enhance local control in select high-risk subtypes, though survival benefit remains inconsistent. Radiotherapy continues to play a crucial role in gynecologic oncology, with modern image-guided and intensity-modulated techniques improving precision and safety. Emerging paradigms including integration with systemic and immunologic therapies, and adaptive individualized planning promise to further refine its impact on survival and quality of life in selected patient populations.
Referanslar
Ozer, E.E., et al., Comparison of point a based plans with clinical target volume-based three-dimensional plans using dose-volume parameters in small lesion of cervical cancer brachyterapy. European Journal of Gynaecological Oncology, 2021. 42(5).
Pagano, F., et al., Intraoperative Radiation Therapy for Gynecologic Malignancies: When Is It Indicated? Cancers, 2025. 17(7): p. 1240.
Donovan, E.K., et al., Stereotactic Ablative Radiotherapy for Gynecological Oligometastatic and Oligoprogessive Tumors. JAMA Oncology, 2024. 10(7): p. 941-948.
Mayadev, J.S., et al., Global challenges of radiotherapy for the treatment of locally advanced cervical cancer. Int J Gynecol Cancer, 2022. 32(3): p. 436-445.
Olawaiye, A.B., et al., The new (Version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer. CA: a cancer journal for clinicians, 2021. 71(4): p. 287-298.
Bhatla, N., et al., Cancer of the cervix uteri. International journal of gynecology & obstetrics, 2018. 143: p. 22-36.
Mayadev, J., et al., Underutilization of brachytherapy and disparities in survival for patients with cervical cancer in California. Gynecologic oncology, 2018. 150(1): p. 73-78.
Shrivastava, S., et al., Cisplatin chemoradiotherapy vs radiotherapy in FIGO stage IIIB squamous cell carcinoma of the uterine cervix: a randomized clinical trial. JAMA oncology, 2018. 4(4): p. 506-513.
Chiew, K.L., et al., Assessing guideline adherence and patient outcomes in cervical cancer. Asia‐pacific Journal of Clinical Oncology, 2017. 13(5): p. e373-e380.
Management of Cervical Cancer: Strategies for Limited-resource Centres - A Guide for Radiation Oncologists. 2013, Vienna: INTERNATIONAL ATOMIC ENERGY AGENCY.
Shrivastava, S.K., U. Mahantshetty, and K. Narayan, Principles of radiation therapy in low-resource and well-developed settings, with particular reference to cervical cancer. International Journal of Gynecology & Obstetrics, 2015. 131: p. S153-S158.
Suneja, G., et al., American Brachytherapy Society: Brachytherapy treatment recommendations for locally advanced cervix cancer for low-income and middle-income countries. Brachytherapy, 2017. 16(1): p. 85-94.
Chopra, S.J., et al., National cancer grid of India consensus guidelines on the management of cervical cancer. Journal of global oncology, 2018. 4: p. 1-15.
Oonk, M.H.M., et al., European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023. Int J Gynecol Cancer, 2023. 33(7): p. 1023-1043.
Nout, R.A., et al., ESTRO/ESGO/SIOPe Guidelines for the management of patients with vaginal cancer. International Journal of Gynecological Cancer, 2023. 33(8): p. 1185-1202.
Abu-Rustum, N.R., et al., Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 2024. 22(2): p. 117-135.
Oonk, M.H.M., et al., Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II. Journal of Clinical Oncology, 2021. 39(32): p. 3623-3632.
Horowitz, N.S., et al., Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279. J Clin Oncol, 2024. 42(16): p. 1914-1921.
Huang, C.C., et al., Recent advances in gynecologic radiation oncology. Cancer, 2025. 131(9): p. e35888.
Proppe, L., et al., Systematic review–Adjuvant radiotherapy of the vulva in primary vulvar cancer. Gynecologic Oncology, 2024. 190: p. 264-271.
Shen, J., et al., Abdominopelvic lymphatic drainage area irradiation for consolidative radiotherapy of advanced ovarian carcinoma: analysis of clinical application efficacy and dosimetric verification. World Journal of Oncology, 2022. 13(3): p. 145.
Shen, J., et al., Clinical application of radiotherapy in patients with oligometastatic ovarian cancer: a sharp tool to prolong the interval of systemic treatment. Discover Oncology, 2022. 13(1): p. 82.
Lee, B.M., et al., Radiotherapy in recurrent ovarian cancer: updated results of involved-field radiation therapy. International Journal of Gynecological Cancer, 2023. 33(7): p. 1106-1111.
Zhuang, Y. and H. Yang, The Significance of Radiotherapy in Ovarian Clear Cell Carcinoma: A Systematic Review and Meta-Analysis. Cancer Control, 2023. 30: p. 10732748231179291.
Huck, C., et al., SBRT in recurrent oligometastatic ovarian cancer: An EORTC Y-ECI GCG systematic review. Clin Transl Radiat Oncol, 2025. 53: p. 100981.
Kopatsaris, S., et al., Management of Endometrial Cancer: A Comparative Review of Guidelines. Cancers (Basel), 2024. 16(21).
Harkenrider, M.M., et al., Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice Guideline. Practical Radiation Oncology, 2023. 13(1): p. 41-65.
Institute, N.C., Endometrial cancer treatment (PDQ®): health professional version. 2002.
Cao, X., et al., Guidelines for radiation therapy for endometrial cancer by Brachytherapy Committee of China Anti-Cancer Association (V 2025.1). Holistic Integrative Oncology, 2025. 4(1): p. 53.
van den Heerik, A.S.V.M., et al., Vaginal brachytherapy management of stage I and II endometrial cancer. International Journal of Gynecological Cancer, 2022. 32(3): p. 304-310.
Meyer, L.A., et al., Postoperative radiation therapy for endometrial cancer: American Society of Clinical Oncology clinical practice guideline endorsement of the American Society for Radiation Oncology evidence-based guideline. Journal of Clinical Oncology, 2015. 33(26): p. 2908-2913.
Ricotta, G., et al., Endometrial Stromal Sarcoma: An Update. Cancers, 2025. 17(11): p. 1893.
Hou, H.L., et al., The prognosis factor of adjuvant radiation therapy after surgery in uterine sarcomas. Onco Targets Ther, 2015. 8: p. 2339-44.
Hao, Z. and S. Yang, The role of postoperative radiotherapy in patients with uterine sarcomas: A PSM-IPTW analysis based on SEER database. Frontiers in Surgery, 2022. 9: p. 985654.
Ray-Coquard, I., et al., ESGO/EURACAN/GCIG guidelines for the management of patients with uterine sarcomas. International Journal of Gynecological Cancer, 2024. 34(10): p. 1499-1521.
Yilmaz, U., et al., Adjuvant radiotherapy for uterine carcinosarcoma: A retrospective assessment of treatment outcomes. Journal of Cancer Research and Therapeutics, 2019. 15(6): p. 1377-1382.
